Avectas
Emer Hackett is a Principal Scientist at Avectas since October 2018. Prior to that, Emer worked as a Postdoctoral Researcher at Trinity College Dublin from October 2014 to October 2021, focusing on studying TB, metabolism, and innate immune training in the Macrophage Homeostasis Group in TBSI, Dublin. Emer also worked as a Summer Researcher at Queen's University Belfast in June 2013. Emer holds a Bachelor's degree in Molecular Medicine from Trinity College Dublin, where Emer studied from 2010 to 2014.
This person is not in the org chart
This person is not in any offices
Avectas
1 followers
Avectas is a cell engineering business focused on improving the cost, manufacturing, and patient outcomes for the next generation of cellular therapies. Avectas is developing a unique delivery technology platform, Solupore®, to enable the ex-vivo manufacture of gene-modified cell therapy products, with partners.